CorMedix, Inc. (CRMD)
8.61
+0.23
(+2.74%)
USD |
NASDAQ |
Sep 02, 16:00
8.61
0.00 (0.00%)
After-Hours: 18:00
CorMedix Cash from Operations (Annual) : 175.05M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 175.05M |
| December 31, 2024 | -50.61M |
| December 31, 2023 | -38.41M |
| December 31, 2022 | -24.36M |
| December 31, 2021 | -21.16M |
| December 31, 2020 | -21.97M |
| December 31, 2019 | -15.28M |
| December 31, 2018 | -23.70M |
| December 31, 2017 | -28.59M |
| Date | Value |
|---|---|
| December 31, 2016 | -22.27M |
| December 31, 2015 | -12.36M |
| December 31, 2014 | -6.541M |
| December 31, 2013 | -3.556M |
| December 31, 2012 | -2.346M |
| December 31, 2011 | -6.297M |
| December 31, 2010 | -3.668M |
| December 31, 2009 | -2.146M |
| December 31, 2008 | -4.113M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Innoviva, Inc. | 196.93M |
| Zevra Therapeutics, Inc. | -1.598M |
| Filana Therapeutics, Inc. | -32.25M |
| Eloxx Pharmaceuticals, Inc. | -6.327M |
| Cannabis Global, Inc. | -0.2899M |